NCT01976936: A trial that was reported late by Mitchell S Elkind
This trial has reported, although it was 57 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01976936 |
|---|---|
| Title | A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days. |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Feb. 28, 2009 |
| Completion date | Jan. 31, 2017 |
| Required reporting date | Jan. 31, 2018, midnight |
| Actual reporting date | March 29, 2018 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | 57 |